BAYER HLTHCARE FDA Approval NDA 018181

NDA 018181

BAYER HLTHCARE

FDA Drug Application

Application #018181

Application Sponsors

NDA 018181BAYER HLTHCARE

Marketing Status

Discontinued001
Over-the-counter002

Application Products

001SOLUTION;TOPICAL1% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1MYCELEXCLOTRIMAZOLE
002Solution; Topical1%0MYCELEXCLOTRIMAZOLE

FDA Submissions

TYPE 5; Type 5 - New Formulation or New ManufacturerORIG1AP1979-01-15STANDARD
LABELING; LabelingSUPPL5AP1990-03-16
LABELING; LabelingSUPPL6AP1991-04-01
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1993-05-12STANDARD
LABELING; LabelingSUPPL8AP1995-04-03
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1997-05-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2001-08-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL11AP2001-08-29STANDARD

Submissions Property Types

SUPPL7Null0
SUPPL9Null0
SUPPL10Null0
SUPPL11Null0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 18181
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.